ZBIO
Zenas BioPharma, Inc.
28.30$
+1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 91.5% | 87.7% | 80.9% | 94.3% | 97.6% | 96.2% | 95.2% | 95.1% | 92.1% | 91.5% | 97.7% | 93.2% | |
| 86.3% | 83.4% | 75.7% | 92.0% | 89.2% | 86.4% | 58.9% | 15.0% | 35.9% | 28.8% | 66.9% | 28.0% | |
| 86.3% | 83.4% | 75.7% | 92.0% | 95.9% | 94.8% | 93.6% | 93.2% | 90.3% | 89.5% | 95.9% | 91.7% | |
| – | – | – | – | – | – | – | – | – | – | 0.1% | 0.1% | |
| 341.4% | 431.1% | 614.8% | 19.6% | 10.9% | 15.5% | 14.8% | 18.2% | 39.0% | 36.9% | 55.1% | 64.8% | |
| 18.6% | 34.1% | 61.8% | 19.6% | 10.9% | 15.5% | 14.7% | 18.2% | 16.3% | 16.3% | 8.2% | 9.4% | |
| 0.7% | 0.8% | 1.1% | 0.2% | 0.1% | 0.2% | 0.3% | 0.3% | 0.2% | 0.3% | 0.1% | 0.1% | |
| 2.7% | 7.9% | 18.0% | 4.2% | 3.7% | 4.6% | 6.0% | 2.7% | 2.0% | 1.9% | 1.2% | 1.1% | |
| 23.9% | 29.8% | 42.8% | – | – | – | – | – | – | – | 35.5% | 42.3% | |
| -241.4% | -331.1% | -514.8% | 80.4% | 89.1% | 84.5% | 85.2% | 81.8% | 61.0% | 63.1% | 44.9% | 35.2% | |
| -245.6% | -337.9% | -526.4% | -148.1% | -83.0% | -104.7% | -126.1% | -161.5% | -162.9% | -199.4% | -113.2% | -136.5% | |
| 49.9% | 56.2% | 78.1% | 19.2% | 10.4% | 11.3% | 12.5% | 14.3% | 13.1% | 12.1% | 7.4% | 9.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.